Work

Acute Ocriplasmin Retinopathy

Year: 2015

Type: article

Abstract: Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan M. W. Johnson reports serving as Data and Safety Monitoring Board member for GlaxoSmithKline and Oraya (both unrelated to the submitted work) and clinical trial funding unrelated to the submitted work from Hoffman-LaRoche. A. T. Fahim reports a research grant from the Juliette RP Foundation and stock in Isis Pharmaceuticals and Pure Healthy Back, all unrelated to the submitted work. R. C. Rao is funded in part by an institutional K12 training grant from the NIH.

Source: Retina

DOI: 10.1097/iae.0000000000000667

Authors: Mark W. Johnson, Abigail T. Fahim, Rajesh C. Rao

Institution: University of Michigan

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Eye Institute